Michael Liang, Partner at Baird Capital, invests in early- to expansion-stage healthcare companies. See sector focus and contact routes.
Michael Liang, Partner at Baird Capital, invests in early- to expansion-stage healthcare companies, with a typical check size of $100K–$5.0M and a sweet spot around $1.5M, focusing on sectors including medical devices, life sciences, digital health, health IT, and biotechnology. His notable portfolio includes Alto Neuroscience, Greenlight Biosciences, OncoHealth, Amphora Medical, and Jumpcode Genomics, for which he has served on boards or led investments. Liang’s distinctive thesis emphasizes partnering with entrepreneurs to build innovative, high-growth healthcare firms, leveraging his PhD in biophysical chemistry and prior operating experience in spinal orthopedics to evaluate science-driven ventures.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with comparable investors when building a target list.
Investors like Michael Liang · Full investor directory · Investor access · Company funding database